EDIT FY 2019 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21M-35.7% YoY

Gross Profit

-$76M-372.0% margin

Operating Income

-$141M-686.4% margin

Net Income

-$134M-651.4% margin

EPS (Diluted)

$-2.47

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$47M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$509M

Total Liabilities

$246M

Stockholders' Equity

$262M

Cash & Equivalents

$238M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$32M	-35.7%
Gross Profit	-$76M	-$59M	-30.1%
Operating Income	-$141M	-$114M	-23.9%
Net Income	-$134M	-$110M	-21.6%